Literature DB >> 29482816

Impaired cerebrovascular reactivity in obstructive sleep apnea: a case-control study.

Laura B Ponsaing1, Ulrich Lindberg2, Egill Rostrup3, Helle K Iversen4, Henrik B W Larsson2, Poul Jennum5.   

Abstract

OBJECTIVE: Obstructive sleep apnea (OSA) is an independent risk factor for stroke. Little is known about the cerebrovascular hemodynamic changes during apnea. Hypercapnia occurs in apneas and hypopneas, and a reduced cerebral vasodilatory response to CO2 could compromise the cerebral blood flow (CBF). Therefore, we aimed to evaluate whether the apnea-hypopnea index (AHI) affected the cerebrovascular response to CO2.
METHODS: A total of 11 patients with OSA were compared to 16 controls. We assessed the cerebrovascular responses with arterial spin labeling (ASL) and blood oxygen level-dependent (BOLD) magnetic resonance imaging during hypercapnia or breath-holding tasks.
RESULTS: The CBF response to CO2 was impaired with increasing AHI (average CBF: p = 0.018; gray matter: p = 0.038; white matter: p = 0.045), that is, increased OSA severity. When comparing the OSA patients to the control subjects, the OSA patients had a significantly reduced CO2 response of the white matter CBF (p = 0.04). However, the BOLD response to CO2 and the breath-holding task did not show any significant differences between OSA patients and control subjects.
CONCLUSION: The cerebrovascular CO2 reactivity, measured by the CBF, was impaired with increasing AHI, that is, OSA severity. These findings may add to the understanding of the increased stroke risk found in OSA patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arterial spin labeling; Blood oxygen level-dependent contrast; Cerebrovascular reactivity; Hypercapnia; Magnetic resonance imaging; Obstructive sleep apnea

Mesh:

Year:  2017        PMID: 29482816     DOI: 10.1016/j.sleep.2017.10.010

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  6 in total

1.  Sleep-disordered breathing and cerebral small vessel disease-acute and 6 months after ischemic stroke.

Authors:  Sofie Amalie Simonsen; Adam Vittrup Andersen; Anders Sode West; Frauke Wolfram; Poul Jennum; Helle K Iversen
Journal:  Sleep Breath       Date:  2021-09-02       Impact factor: 2.655

2.  [A long-term ischemic stroke risk score model in patients aged 60 years and older with obstructive sleep apnea: a multicenter prospective cohort study].

Authors:  X Su; J Han; Y Gao; L Fan; Z He; Z Zhao; J Lin; J Guo; K Chen; Y Gao; L Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-03-20

3.  Sleep and Stroke: New Updates on Epidemiology, Pathophysiology, Assessment, and Treatment.

Authors:  H Lee Lau; Tanja Rundek; Alberto R Ramos
Journal:  Curr Sleep Med Rep       Date:  2019-05-02

4.  Impact of mandibular advancement device therapy on cerebrovascular reactivity in patients with carotid atherosclerosis combined with OSAHS.

Authors:  Lu Qin; Na Li; Junyao Tong; Zeliang Hao; Lili Wang; Ying Zhao
Journal:  Sleep Breath       Date:  2021-01-07       Impact factor: 2.816

Review 5.  Treatment-Emergent Central Apnea: Physiologic Mechanisms Informing Clinical Practice.

Authors:  Salam Zeineddine; M Safwan Badr
Journal:  Chest       Date:  2021-01-23       Impact factor: 10.262

6.  Cerebrovascular Reactivity Measurement Using Magnetic Resonance Imaging: A Systematic Review.

Authors:  Emilie Sleight; Michael S Stringer; Ian Marshall; Joanna M Wardlaw; Michael J Thrippleton
Journal:  Front Physiol       Date:  2021-02-25       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.